This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Shiftbio. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gi-beom Kim: Innovator in Cancer Treatment
Introduction
Gi-beom Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Gi-beom Kim holds a patent for a recombinant plasma membrane-based vesicle designed for treating cancer. This invention specifically relates to a recombinant plasma membrane-based vesicle that includes a VSV-G mutated protein, where histidine at the 162nd amino acid position has been substituted with arginine. The patent also encompasses a pharmaceutical composition for treating cancer that utilizes this recombinant vesicle.
Career Highlights
Gi-beom Kim is associated with Shiftbio, a company focused on advancing biotechnological solutions. His work at Shiftbio highlights his commitment to developing effective treatments for cancer patients.
Collaborations
Some of his notable coworkers include Yoo Soo Yang and In-San Kim, who contribute to the innovative environment at Shiftbio.
Conclusion
Gi-beom Kim's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaboration with colleagues underscore the importance of research in developing new treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile